B. Riley Starts CytoSorbents (CTSO) at Buy
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
B. Riley initiated coverage on CytoSorbents (NASDAQ: CTSO) with a Buy rating and a price target of $11.25.
Shares of CytoSorbents closed at $5.63 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aegis Capital Starts CytoSorbents (CTSO) at Buy
- UPDATE: MKM Partners Upgrades Masco (MAS) to Buy
- UPDATE: Stifel Upgrades Legacy Reserves (LGCY) to Hold
Create E-mail Alert Related CategoriesNew Coverage
Related EntitiesB. Riley
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!